Evofem Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Evofem Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011693
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Evofem Inc (Evofem) is a healthcare solution provider that discovers, develops and commercializes prescription and consumer products. The company’s product pipeline includes amphora and nestorone. Evofem improves reproductive health and wellness options for women. It develops products for contraception, itching, burning and stinging, fine lines, wrinkles, skin tone, texture, color and elasticity. The company concentrates on women’s health and reproductive care, contraception, and the prevention of STI. It partners with WomanCare Global to market its products. Evofem is headquartered in San Diego, California, the US.

Evofem Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Evofem Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Evofem Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Evofem Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Evofem Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Evofem Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Evofem Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Evofem Raises USD20 Million in Financing Round 10
Merger 11
Neothetics and Evofem Biosciences to Merge 11
Equity Offering 13
Evofem Raises USD25 Million in Private Placement of Shares 13
Evofem Inc – Key Competitors 14
Evofem Inc – Key Employees 15
Evofem Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Corporate Communications 17
Dec 16, 2016: Evofem Biosciences Appoints Dr. David Friend as Chief Scientific Officer 17
Aug 29, 2016: Evofem Biosciences Appoints Russell Barrans as Chief Commercial Officer 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Evofem Inc, Medical Equipment, Key Facts 2
Evofem Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Evofem Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Evofem Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Evofem Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Evofem Inc, Deals By Market, 2011 to YTD 2017 8
Evofem Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Evofem Raises USD20 Million in Financing Round 10
Neothetics and Evofem Biosciences to Merge 11
Evofem Raises USD25 Million in Private Placement of Shares 13
Evofem Inc, Key Competitors 14
Evofem Inc, Key Employees 15

★海外企業調査レポート[Evofem Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • iX Biopharma Ltd (42C):企業の財務・戦略的SWOT分析
    Summary iX Biopharma Ltd (iX Biopharma) is a pharmaceutical company that provides that offers drug delivery and formulation. The company's pipeline product portfolio includes development of drugs for various indications such as opioid-sparing for acute, severe and chronic pain; male erectile dysfunc …
  • Bharat Sanchar Nigam Ltd:企業の戦略的SWOT分析
    Bharat Sanchar Nigam Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • NHPC Ltd (NHPC):企業の財務・戦略的SWOT分析
    NHPC Ltd (NHPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • OMV Petrom SA (SNP):企業の財務・戦略的SWOT分析
    OMV Petrom SA (SNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Servest Group Ltd:企業の戦略的SWOT分析
    Servest Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Cyient Ltd (CYIENT):企業の財務・戦略的SWOT分析
    Cyient Ltd (CYIENT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Citibank Berhad:企業の戦略的SWOT分析
    Citibank Berhad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Pellegrini S.p.A.:企業の戦略・SWOT・財務分析
    Pellegrini S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Pellegrini S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • PHX Energy Services Corp (PHX):石油・ガス:M&Aディール及び事業提携情報
    Summary PHX Energy Services Corp (PHX Energy), formerly Phoenix Technology Income Fund is an energy service company that manufactures, designs, and engineers directional drilling technologies. The corporation’s equipment includes RADD, P-360 MWD, 360-CV MWD, E-360 MWD, 360 RWD, and performance motor …
  • NAPEC Inc. (NPC)-エネルギー分野:企業M&A・提携分析
    Summary NAPEC Inc. (NAPEC), formerly CVTech Group Inc., is an energy services company that provides construction and maintenance services. It builds and maintains electrical transmission and distribution systems, solar panel farms, and natural gas networks. The company installs gas-powered and elect …
  • Thetis Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Thetis Pharmaceuticals LLC (Thetis Pharma) is a drug manufacturing company that offers novel immuno-resolving therapies. The company develops and manufactures drugs for type two diabetes and chronic conditions. Its pipeline products include TP252, TP6211, TP113, and TP 101. Thetis Pharma’s T …
  • Provectus Biopharmaceuticals Inc (PVCT):医療機器:M&Aディール及び事業提携情報
    Summary Provectus Biopharmaceuticals Inc (Provectus) is a developer of pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for locally advanced cutaneous melanoma, PV-10 for metastatic liver cancer and PV-10 for neuroendocrine tumors [NET], …
  • McKesson Corporation:企業の戦略・SWOT・財務情報
    McKesson Corporation - Strategy, SWOT and Corporate Finance Report Summary McKesson Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Laurus Labs Ltd (LAURUSLABS):製薬・医療:M&Aディール及び事業提携情報
    Summary Laurus Labs Ltd (Laurus Labs) is a drug development company that manufactures active pharmaceutical ingredients. The company develops products through its business divisions such as laurus generics, ingredients and synthesis. It offers active pharmaceutical ingredients and intermediates for …
  • Symbiomix Therapeutics LLC-製薬・医療分野:企業M&A・提携分析
    Summary Symbiomix Therapeutics LLC (Symbiomix) is a drug development company that offers development and commercialization of novel medicines. The company offers SYM-1219, for the treatment of several serious infections in women including bacterial vaginosis. Its SYM-1219 contains secnidazole, nitro …
  • TESARO Inc (TSRO):医療機器:M&Aディール及び事業提携情報
    Summary TESARO Inc (TESARO) is an oncology-focused biopharmaceutical company that focuses on developing in-licensed, oncology-related product candidates and discovery of new candidates. It develops products using different approaches, comprising small molecules and immuno-oncology antibodies. The co …
  • Statkraft AS:電力:M&Aディール及び事業提携情報
    Summary Statkraft AS (Statkraft), a subsidiary of Statkraft SF, is a power utility which produces electricity and supplies district heating. It generates power from hydro, wind, gas, solar and bio-power sources. The company develops hydroelectric power plants in emerging markets outside Europe. Stat …
  • Forty Seven Inc (FTSV):製薬・医療:M&Aディール及び事業提携情報
    Summary Forty Seven Inc (Forty Seven), formerly CD47 Sciences Inc is a clinical-stage immuno-oncology company that focuses on the development of therapies to treat cancer. The company’s lead molecule Hu5F9-G4 is a monoclonal antibody that is used against the CD47 receptor. Its monoclonal antibody is …
  • Actinium Pharmaceuticals Inc (ATNM):企業の財務・戦略的SWOT分析
    Summary Actinium Pharmaceuticals Inc (ATNM), formerly Cactus Ventures Inc is a biopharmaceutical company that provides development of cancer immunotherapies. The company provides pipeline products such as Iomab-B that is used for hematopoietic stem cells transplantation. It provides Iomab-B through …
  • Sterlite Power Grid Ventures Limited:企業の戦略的SWOT分析
    Sterlite Power Grid Ventures Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆